FRA
MRVI icon

Frank Rimerman Advisors’s Maravai LifeSciences MRVI Stock Holding History

Frank Rimerman Advisors’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,593
Closed -$57.7K – 541
2024
Q4 		$57.7K Sell
10,593
-44,462
-81% -$242K ﹤0.01% 516
2024
Q3 		$458K Sell
55,055
-613
-1% -$5.09K 0.03% 343
2024
Q2 		$399K Buy
+55,668
New +$399K 0.03% 388